透景生命：关于对外投资参股公司的进展公告

Core Viewpoint - The company, Shanghai TuoJing Life Technology Co., Ltd., has announced a strategic investment in Huihe Biotechnology (Shanghai) Co., Ltd., aiming to enhance its long-term development strategy through this partnership [2]. Group 1: Investment Details - The company will invest a total of 68 million RMB to subscribe to the increased registered capital of 175,992 RMB in Huihe Biotechnology [2]. - Following this investment, the company will hold a 9.2141% equity stake in Huihe Biotechnology [2]. - All parties involved in the transaction have completed the necessary delivery work as per the agreements [2].